Evoke Pharma Inc expected to post a loss of 66 cents a share - Earnings Preview

Evoke Pharma

08/11/2022 02:28

* Evoke Pharma Inc  EVOK.OQ   EVOK.O  is expected to show a
fall
in quarterly revenue when it reports  results on November 9. 
    * The Solana Beach California-based  company is expected to
report
 a 38.5% decrease in revenue to $572 thousand from $930 thousand
a year ago, according to the estimate from one analyst, based on
Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Evoke Pharma Inc is
for a
loss of 66 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Evoke
Pharma Inc
is $63.5​, above​ its last closing price of $1.68. ​​​

This summary was machine generated November 8 at 02:28 GMT.  All
figures in US dollars  unless otherwise stated